Charles River Laboratories International Inc CRLの前四半期の収益はどうでしたか?
Charles River Laboratories International Incの収益見積もりはいくらですか?
Charles River Laboratories International Incの収益品質スコアはどれくらいですか?
Charles River Laboratories International Incはいつ収益を報告しますか?
Charles River Laboratories International Incの予想収益はいくらですか?
Charles River Laboratories International Incは収益予想を上回りましたか?
360レポート
主要データ
前終値
$185.7
始値
$182
当日レンジ
$178.27 - $184.45
52週レンジ
$91.86 - $228.88
取引高
1.0M
平均取引高
766.9K
1株当たり利益(TTM)
-1.56
配当利回り
--
時価総額
$8.9B
CRLとは何ですか?
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. The company is headquartered in Wilmington, Massachusetts and currently employs 18,600 full-time employees. The company went IPO on 2000-06-23. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.